Quick Answer: Compounded semaglutide often has a Beyond-Use Date (BUD) of several months if unopened, but once a multi-dose vial is punctured, it is generally recommended to be used or discarded within 28 days to ensure sterility and potency
Choosing a GLP-1 medication when you have Hashimoto's thyroiditis requires careful consideration of your individual health needs
It gives providers additional tools to finetune treatment as required
4,5 However, newer therapies, including the glucagon-like peptide 1 receptor agonist (GLP-1 RA) semaglutide and the dual GLP-1 RA/gastric inhibitory polypeptide (GIP) agonist tirzepatide, have demonstrated substantial weight reduction in patients with obesity, with and without type 2 diabetes (T2D), in randomized clinical trials (RCTs)
Of course, the following is just a blanket list, and results may vary based on the individual